Data presented at American College of Cardiology (ACC) 2020

Due to COVID-19 concerns, many medical congresses are being presented virtually. Virtual congress materials from ACC can be accessed at https://accscientificsession.acc.org/

Posters:

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial.
Effects of canagliflozin on cardiovascular, renal and safety outcomes by baseline loop diuretic use: data from the CREDENCE trial.
Canagliflozin (CANA) reduces cardiovascular (CV) and renal events independent of baseline heart failure (HF): a CREDENCE secondary analysis.
Effects of canagliflozin on stroke in the CREDENCE trial.

Search Medical Information

Data presented at American College of Cardiology (ACC) 2020

Product Announcements

Resources

Who are our experts?

Need Help?